David B. McKinley @RepMcKinley
In contrast to H.R. 3, the bipartisan alternative H.R. 19, will not only lower drug prices, but will protect innovation and research into new medicines and cures for diseases like Alzheimer's, rheumatoid arthritis, ALS, diabetes and Parkinson's. #MoreCures — PolitiTweet.org